Viewing Study NCT06037395


Ignite Creation Date: 2025-12-24 @ 1:36 PM
Ignite Modification Date: 2025-12-31 @ 9:14 AM
Study NCT ID: NCT06037395
Status: COMPLETED
Last Update Posted: 2023-09-14
First Post: 2023-09-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects
Sponsor: Celltrion
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-10-06
Start Date Type: ACTUAL
Primary Completion Date: 2022-10-20
Primary Completion Date Type: ACTUAL
Completion Date: 2022-10-20
Completion Date Type: ACTUAL
First Submit Date: 2023-09-07
First Submit QC Date: None
Study First Post Date: 2023-09-14
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-09-07
Last Update Post Date: 2023-09-14
Last Update Post Date Type: ACTUAL